Targets for Cancer IO: A Deep Dive Series

This program is supported, in part, by grants from these sponsors (as of April 25, 2024):

     Silver Sponsors:                                                                                                                                Bronze Sponsor:

 

Contact Development@sitcancer.org for more information on how your organization's support can help advance cancer immunotherapy and make "cure" a reality.

This series will include seven live webinars addressing various hot topics in immuno-oncology.

The Society for Immunotherapy of Cancer (SITC) is pleased to announce our fourth Targets for Cancer IO: A Deep Dive live webinar series.

Key leaders in the field who are experts in their respective fields will provide an overview of the current state of the science and address questions about its future. 

An interactive Q&A session will follow the topic overview, providing participants with the opportunity to ask in-depth questions of the faculty as well as offering a forum for networking and initiation of collaborations with others working in a similar field.

Target Audience

Basic, clinical and translational researchers in academia and industry and members of the investment community.

Enduring Materials

Four weeks following the live webinars, the enduring materials from the webinar, including recording and presentation (as permitted by speakers) will be made available for purchase. 

To note, for those that registered for/attended the webinar, access is granted immediately following the posting of the materials and can be accessed through the "My Library" button under "The Connect Community" tab at the top of the page. An email will be sent once they are posted following the live program - please allow up to one week for them to be posted.

Program Organizers

Mario Sznol, MD

Chair

Mario Sznol, MD
Yale School of Medicine

Dan Chen, MD, PhD

Co-Chair

Daniel S. Chen, MD, PhD
Synthetic Design Lab

Elizabeth Jaffee, MD, FAIO

Elizabeth M. Jaffee, MD, FAIO
Sidney Kimmel Cancer Center, Johns Hopkins University

Nils Lonberg, PhD

Nils Lonberg, PhD
Canaan

Ira Mellman, PhD

Ira Mellman, PhD
Genentech

Howard Kaufman, MD, FACS

Katy Rezvani, MD, PhD
The University of Texas MD Anderson Cancer Center

Jeff Weber, MD, PhD

Jeffrey S. Weber, MD, PhD, FAIO
NYU Langone Medical Center

Browse Webinars

LIVE WEBINAR 1

Personalized Vaccines


Date of Live Event
Wednesday, April 3, 2024 – 12–2 p.m. EDT

Moderators

    Lelia Delamarre, PhD
    Genentech

    Robert Seder, MD
    National Institutes of Health (NIH)

Faculty

Vinod Balachandran, MD
Memorial Sloan Kettering 
Cancer
Center

Megan L. Burger, PhD
Oregon Health & Science University

Morena D'Alise, PhD
Nouscom

This webinar will explore the processes of neoantigen identification and selection for cancer vaccine development and the role of dark antigens, cancer-specific neoantigens derived from non-coding parts of the genome. The webinar will also address vaccine-induced changes in the tumor microenvironment and how these changes can inform future vaccine development and/or delivery.

LIVE WEBINAR 2

Tertiary Lymphoid Aggregates 


Date of Live Event
Wednesday, May 22, 2024 – 12–2 p.m. EDT

Moderators

Wolf-Hervé Fridman, MD, PhD
Cordeliers Research Centre

James Mulé, PhD
Moffitt Cancer Center

Faculty

Roger Li, MD
H. Lee Moffitt Cancer Center

Janis Taube, MD, MSc
Johns Hopkins School of Medicine

Cornelia Trimble, MD
Johns Hopkins University

This webinar will investigate the mechanisms underlying tertiary lymphoid aggregate structure and function within the tumor, and how they translate to clinical benefits. Ongoing therapeutic approaches to stimulate aggregate formation or activate B cells or other immune cells within the aggregates will also be discussed.

LIVE WEBINAR 3

Tumor-targeted Delivery of Immune Modulators


Date of Live Event
Tuesday, July 9, 2024 – 12–2 p.m. EDT

Moderators

Rafi Ahmed, PhD, FAIO
Emory University School of Medicine

Pablo Umaña, PhD
Roche Innovation Center Zurich

Faculty

Laura Codarri Deak, PhD
Roche Innovation Center Zurich

Daniela Thommen, MD, PhD
The Netherlands Cancer Institute

K. Dane Wittrup, PhD
Koch Institute for Integrative Cancer Research at MIT

This webinar will discuss the latest research in tumor-targeted therapies, drug delivery systems and agents that target the tumor to deliver immunostimulatory agents and restore anti-tumor immunity. Current studies investigating the clinical potential of these therapies, such as engineered antibodies, STING agonists and oncolytic viruses, will be addressed, as well as future outlooks for these therapies.

LIVE WEBINAR 4

Fibroblast in the TME


Date of Live Event
Wednesday, Sept. 4, 2024 – 12–2 p.m. EDT

Moderators

Ellen Puré, PhD
University of Pennsylvania

Hélène Salmon, PhD
Institut Curie

Faculty

Akshay Krishnamurty, PhD
Genentech

This webinar will address the heterogeneity of fibroblasts within the tumor and the molecular mechanisms underlying their differentiation and function. Current efforts to develop therapeutics that restore anti-cancer immunity by targeting T cell-excluding fibroblasts and their signaling pathways will also be discussed.

LIVE WEBINAR 5

CD3 Engagers in Solid Tumors and TCR by CD3 in Solid Tumors


Date of Live Event
Wednesday, Sept. 25, 2024 – 12–2 p.m. EDT

Moderators

Jeremy Myers, PhD
EvolveImmune

Dmitris Skokos, PhD
Regeneron Pharmaceuticals, Inc.

This webinar will address current studies to develop more effective, safer CD3-targeting immunotherapies that maintain clinical efficacy within the immunosuppressive tumor microenvironment while minimizing cytokine release and other on-target, off-tumor toxicities.

LIVE WEBINAR 6

Role of Neutrophils in Anti-tumor Immunity


Date of Live Event
Wednesday, Oct. 23, 2024 – 12–2 p.m. EDT

Moderators

Andres Hidalgo, PhD
Fundacion Centro Nacional de Investigaciones

Brahm Segal, MD
Roswell Park Comprehensive Cancer Center

This webinar will address signaling pathways in the tumor microenvironment that direct neutrophil differentiation and function and how these insights can inform the development of neutrophil-targeting therapies that enhance the anti-tumor immune response.

LIVE WEBINAR 7

Hot Topic


Date of Live Event
Dec. 2024 – TBA

Registration Rates

BUY FOUR, GET THE REST FREE

As an added benefit, SITC members are eligible to receive a discount on the full series, as well as individual webinars, if purchased separately. Additionally, at the time of registration, if four of the seven webinars are purchased, you are able to register for the remaining three webinars at no additional cost.

SITC Member Pricing - Targets for Cancer IO: A Deep Dive
  Live Registration Rates Enduring Materials Rates
Fellow in training/student  $25 per (4 webinars for $100) $12.50 per (4 webinars for $50)
Government  $40 per (4 webinars for $160) $20 per (4 webinars for $80)
Health care provider $75 per (4 webinars for $300) $37.50 per (4 webinars for $150)
Industry rep  $150 per (4 webinars for $600) $75 per (4 webinars for $300)
Non-profit org/foundation $25 per (4 webinars for $100) $12.50 per (4 webinars for $50)
Pharmacist $75 per (4 webinars for $300) $37.50 per (4 webinars for $150)
Pharmacist, industry $150 per (4 webinars for $600) $75 per (4 webinars for $300)
Patient/Patient advocate $25 per (4 webinars for $100) $12.50 per (4 webinars for $50)
Nurse  $25 per (4 webinars for $100) $12.50 per (4 webinars for $50)
Nurse, industry $150 per (4 webinars for $600) $75 per (4 webinars for $300)
Low to lower-middle income economies (non-industry) $0 $0
SITC Non-Member Pricing - Targets for Cancer IO: A Deep Dive
  Live Registration Rates Enduring Materials Rates
Fellow in training/student  $40 per (4 webinars for $160) $20 per (4 webinars for $80)
Government  $50 per (4 webinars for $200) $25 per (4 webinars for $100)
Health care provider $100 per (4 webinars for $400) $50 per (4 webinars for $200)
Industry rep  $300 per (4 webinars for $1200) $150 per (4 webinars for $600)
Non-profit org/foundation $40 per (4 webinars for $160) $20 per (4 webinars for $80)
Pharmacist $100 per (4 webinars for $400) $50 per (4 webinars for $200)
Pharmacist, industry $300 per (4 webinars for $1200) $150 per (4 webinars for $600)
Patient/Patient advocate $40 per (4 webinars for $160) $20 per (4 webinars for $80)
Nurse  $40 per (4 webinars for $160) $20 per (4 webinars for $80)
Nurse, industry $300 per (4 webinars for $1200) $150 per (4 webinars for $600)
Low to lower-middle income economies (non-industry) $25 $12.50

Past Programs

2023

2022

2021